ATRICURE INC (ATRC)
US04963C2098 - Common Stock
Taking everything into account, ATRC scores 3 out of 10 in our fundamental rating. ATRC was compared to 196 industry peers in the Health Care Equipment & Supplies industry. ATRC scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. ATRC is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
ATRC had negative earnings in the past year.
In the past year ATRC had a positive cash flow from operations.
In the past 5 years ATRC reported 4 times negative net income.
ATRC had negative operating cash flow in 4 of the past 5 years.
1.2 Ratios
The Return On Assets of ATRC (-4.97%) is better than 62.76% of its industry peers.
ATRC's Return On Equity of -6.54% is fine compared to the rest of the industry. ATRC outperforms 65.31% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -4.97% | ||
| ROE | -6.54% | ||
| ROIC | N/A |
ROA(3y)-1.58%
ROA(5y)-3.56%
ROE(3y)-2.11%
ROE(5y)-6.45%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
ATRC has a better Gross Margin (75.25%) than 86.73% of its industry peers.
ATRC's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for ATRC so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 75.25% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.33%
GM growth 5Y0.61%
2. Health
2.1 Basic Checks
ATRC does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ATRC has more shares outstanding
ATRC has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, ATRC has an improved debt to assets ratio.
2.2 Solvency
An Altman-Z score of 4.59 indicates that ATRC is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 4.59, ATRC is in the better half of the industry, outperforming 76.53% of the companies in the same industry.
ATRC has a Debt/Equity ratio of 0.15. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.15, ATRC is in line with its industry, outperforming 53.57% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.15 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 4.59 |
ROIC/WACCN/A
WACC9.96%
2.3 Liquidity
A Current Ratio of 3.57 indicates that ATRC has no problem at all paying its short term obligations.
ATRC has a Current ratio (3.57) which is comparable to the rest of the industry.
A Quick Ratio of 2.66 indicates that ATRC has no problem at all paying its short term obligations.
The Quick ratio of ATRC (2.66) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.57 | ||
| Quick Ratio | 2.66 |
3. Growth
3.1 Past
ATRC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 25.74%, which is quite impressive.
The Revenue has grown by 20.87% in the past year. This is a very strong growth!
Measured over the past years, ATRC shows a quite strong growth in Revenue. The Revenue has been growing by 14.64% on average per year.
EPS 1Y (TTM)25.74%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-133.33%
Revenue 1Y (TTM)20.87%
Revenue growth 3Y24.58%
Revenue growth 5Y14.64%
Revenue growth Q2Q21.07%
3.2 Future
ATRC is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -2.76% yearly.
Based on estimates for the next years, ATRC will show a quite strong growth in Revenue. The Revenue will grow by 16.53% on average per year.
EPS Next Y-0.75%
EPS Next 2Y10.38%
EPS Next 3Y12.19%
EPS Next 5Y-2.76%
Revenue Next Year16.37%
Revenue Next 2Y15.19%
Revenue Next 3Y14.52%
Revenue Next 5Y16.53%
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
ATRC reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year ATRC is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
A more expensive valuation may be justified as ATRC's earnings are expected to grow with 12.19% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y10.38%
EPS Next 3Y12.19%
5. Dividend
5.1 Amount
No dividends for ATRC!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
ATRICURE INC
NASDAQ:ATRC (4/18/2024, 7:00:00 PM)
After market: 23.39 0 (0%)23.39
-0.06 (-0.26%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap1.11B
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -4.97% | ||
| ROE | -6.54% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 75.25% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.65
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.15 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 3.57 | ||
| Quick Ratio | 2.66 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)25.74%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y-0.75%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)20.87%
Revenue growth 3Y24.58%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y